Establishment of a dermatology global health outreach and residency partnership program in Guatemala
To the Editor: To improve international health equity, residency programs can build sustainable partnerships beyond global health rotations. 1 Heeding this goal, the University of Pennsylvania (Penn) department of dermatology and the Instituto de Dermatolog ıa y Cirugia de Piel (INDERMA), a dermatology residency training program near Guatemala City, Guatemala, founded a partnership in 2013. The Penn-INDERMA dermatology educational exchange program was built upon relationships between Penn and Guatemala established by other university departments. The Botswana-UPenn partnership, with rotating residents supported by the American Academy of Dermatology, served both as inspiration and model. The collaboration established a yearly 1-week rotation at multiple clinics surrounding Lake Atitl an, an underserved rural area in Guatemala. The Atitl an region is home to an indigenous Mayan population with limited access to care. Penn and INDERMA dermatology residents and attending physicians are paired in rotating daily teams at multiple clinic sites.
In 3 years, this effort supported 8 clinic sites (Fig 1, available at http://www.jaad.org), totaling 1046 patient encounters. Sixty-five percent of the patients were female, and 72% were adults ([18 years of age). Common diagnoses included atopic dermatitis, scabies, verruca vulgaris, and acne (Table I) . Rare cases included anhidrotic ectodermal dysplasia, xeroderma pigmentosum, and lamellar ichthyosis. The team performed 57 procedures, including obtaining biopsy specimens, cryotherapy destructions, and malignant excisions. Over the counter medications and compounded prescriptions were provided from Penn and INDERMA, including topical steroids, antibiotics, antifungals, antiparasitics, keratolytics, sunscreen, and moisturizers. Excess medications were donated to the local pharmacy for patients to receive throughout the year.
The Penn-INDERMA collaboration has successfully connected 2 international dermatology programs To the Editor: Subungual melanoma (SM) represents 0.7% to 3.5% of melanoma cases, but often carries a worse prognosis than similarly staged cutaneous melanomas. [1] [2] [3] While longitudinal melanonychia (LM), a brown-black band of the nail plate, is the most common presenting sign of SM (2/3 of cases), it is not specific for SM. 4 In fact, in 1 study, only 6.8% cases of LM showed histologic evidence of SM, with the remaining cases benign etiologies, including subungual hematoma, nail matrix nevus, trauma, nail apparatus lentigo, and melanocytic activation. 3 Therefore, an ABC mnemonic for SM (A: age, Asian, African, Native American; B: band, brown-black, breadth $3 mm, blurred border; C: change; D: digit, dominant hand; E: extension of pigment to nail folds; and F: family or personal history melanoma) was developed in 2000 to facilitate early recognition of SM by physicians and the community. Table I .
Few physicians (32/402, 8%) asked their patients to remove nail polish at every visit. More senior attending (13.6%) than junior attending physicians (5.2%) and residents (1.4%) requested that patients remove nail polish at all examinations ( 2 2 ¼ 40.6; P \.0001). In addition, only 18.2% of dermatologists perform nail examinations at each visit, with the majority (58.0%) examining nails only during total body skin examinations. More frequent nail examinations were higher among junior and senior attending physicians compared to residents ( 2 2 ¼ 82.9; P \.0001).
Many respondents stated that they encounter melanonychia at least once a month (44%), or once a week (23%). Overall, most respondents stated that they were ''fairly confident'' in assessing melanonychia (54.2%); however, many were ''not 
